
Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060
Author(s) -
Charlotte V. Hobbs,
Erin E. Gabriel,
Portia Kamthunzi,
Gerald Tegha,
Jean Tauzie,
Elizabeth Petzold,
Linda BarlowMosha,
Benjamin H. Chi,
Yonghua Li,
Tiina Ilmet,
Brian Kirmse,
Jillian Neal,
Sunil Parikh,
Nagamah Deygoo,
Patrick Jean Philippe,
Lynne Mofenson,
W. H. Prescott,
Jingyang Chen,
Philippa Musoke,
Paul Palumbo,
Patrick E. Duffy,
William Borkowsky,
Severiano Phakati,
Pauline Sambo,
Thikazi de,
Felistas Mbewe,
Ellen Shingalili,
John Mwale,
Esnart Mwaba Nunkwe,
Darius Simbeye,
George Kafulafula,
Namwinga Chintu,
Bosco Kafufu,
Enid Kabugho,
Ali Elbireer,
David Balamusani
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/72mc-9j68
Subject(s) - nucleoside reverse transcriptase inhibitor , virology , protease inhibitor (pharmacology) , reverse transcriptase , reverse transcriptase inhibitor , medicine , antiretroviral therapy , malaria , human immunodeficiency virus (hiv) , nucleoside , viral load , immunology , biology , polymerase chain reaction , gene , biochemistry